Metraipolis › archive › dc_d093182bd451

INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice — Europe PMC PMID:42344483

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344483
DOI
10.3389/fmed.2026.1840071
License (as archived)
solo-consultazione
Archived
2026-10-31T16:11:43.724Z
SHA-256 of the archived text
cd6548e0f311702ad16869b6cfc2dbf78c4ee060b5c40a5a31b184279e51ad99
Stable URL of this page
https://metraipolis.com/documento/dc_d093182bd451

How to cite

INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice — Europe PMC PMID:42344483 — Europe PMC (en), https://europepmc.org/article/MED/42344483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d093182bd451 (Metraipolis archive dc_d093182bd451, sha256 cd6548e0f311702ad16869b6cfc2dbf78c4ee060b5c40a5a31b184279e51ad99)
BibTeX
@misc{dcd093182bd451,
  title = {INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice — Europe PMC PMID:42344483},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344483},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d093182bd451; sha256 cd6548e0f311702ad16869b6cfc2dbf78c4ee060b5c40a5a31b184279e51ad99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344483. Agents can read the archived copy with the MCP tool read_document.